XRCC6BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.177400E-01
Normal-vs-Stage2
7.155600E-01
Normal-vs-Stage3
9.951400E-01
Normal-vs-Stage4
6.491600E-01
Stage1-vs-Stage2
6.267000E-01
Stage1-vs-Stage3
5.390600E-01
Stage1-vs-Stage4
2.097000E-01
Stage2-vs-Stage3
6.692800E-01
Stage2-vs-Stage4
3.209600E-01
Stage3-vs-Stage4
7.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.077400E-01
Normal-vs-AfricanAmerican
9.499200E-01
Normal-vs-Asian
5.526000E-01
Caucasian-vs-AfricanAmerican
4.245400E-01
Caucasian-vs-Asian
3.582500E-02
AfricanAmerican-vs-Asian
4.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.389600E-01
Normal-vs-Female
7.617600E-01
Male-vs-Female
4.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.642400E-01
Normal-vs-Age(41-60Yrs)
4.445000E-01
Normal-vs-Age(61-80Yrs)
8.542400E-01
Normal-vs-Age(81-100Yrs)
4.919600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.488400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.823200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.676000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.747900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.913800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.433400E-01
Normal-vs-Daily Drinker
6.202800E-01
Normal-vs-Weekly Drinker
7.483200E-01
Normal-vs-Occasional Drinker
4.381600E-01
Normal-vs-Social Drinker
6.856400E-01
Non Drinker-vs-Daily Drinker
7.567600E-01
Non Drinker-vs-Weekly Drinker
3.927600E-01
Non Drinker-vs-Occasional Drinker
3.495400E-01
Non Drinker-vs-Social Drinker
8.523200E-01
Daily Drinker-vs-Weekly Drinker
1.375580E-01
Daily Drinker-vs-Occasional Drinker
3.888200E-01
Daily Drinker-vs-Social Drinker
9.368200E-01
Weekly Drinker-vs-Occasional Drinker
5.604300E-02
Weekly Drinker-vs-Social Drinker
2.177600E-01
Occasional Drinker-vs-Social Drinker
4.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.700000E-01
Normal-vs-Grade 2
8.743000E-01
Normal-vs-Grade 3
6.011600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.445400E-01
Grade 1-vs-Grade 3
3.009000E-01
Grade 1-vs-Grade 4
7.700000E-01
Grade 2-vs-Grade 3
3.492400E-01
Grade 2-vs-Grade 4
8.743000E-01
Grade 3-vs-Grade 4
6.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.644200E-01
Normal-vs-NonDiabetic
7.552200E-01
Diabetic-vs-NonDiabetic
9.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.170400E-01
Normal-vs-NoPancreatitis
7.962800E-01
Pancreatitis-vs-NoPancreatitis
8.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.717200E-01
Normal-vs-N1
6.681200E-01
N0-vs-N1
5.464800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.374200E-01
Normal-vs-TP53-NonMutant
3.038600E-01
TP53-Mutant-vs-TP53-NonMutant
7.445600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
